News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Meghan Burke

Advertisement

Articles by Meghan Burke

RI pic 1.png

What Can Pharmaceutical Companies do to Feel Better About Reputation?

ByMeghan Burke
June 14th 2018

Reputation Institute study finds that the reputation of pharma companies is in decline and might get worse before it gets better.

Advertisement

Latest Updated Articles

  • RI pic 1.png
    What Can Pharmaceutical Companies do to Feel Better About Reputation?

    Published: June 14th 2018 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade

2

Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan

3

Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026

4

FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices

5

Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us